Robert W. Baird Issues Pessimistic Forecast for Bath & Body Works (NYSE:BBWI) Stock Price

Bath & Body Works (NYSE:BBWI – Get Free Report) had its price objective cut by stock analysts at Robert W. Baird from $23.00 to $22.00 in a research report issued on Friday, Benzinga reports. The firm currently has a “neutral” rating on the stock. Robert W. Baird‘s price target indicates a potential upside of 17.84% from the company’s previous close.

A number of other equities analysts also recently weighed in on BBWI. Jefferies Financial Group reiterated a “hold” rating and issued a $21.00 target price on shares of Bath & Body Works in a report on Thursday. BMO Capital Markets assumed coverage on shares of Bath & Body Works in a report on Tuesday, September 8th. They set a “market perform” rating and a $20.00 price target for the company. Citigroup raised shares of Bath & Body Works from a “neutral” rating to a “buy” rating and set a $25.00 price objective on the stock in a research report on Tuesday, August 18th. Argus reiterated a “hold” rating on shares of Bath & Body Works in a research note on Wednesday, September 16th. Finally, Deutsche Bank set a $22.00 target price on shares of Bath & Body Works in a research report on Thursday, August 27th. Four investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $22.00.

View Our Latest Stock Report on BBWI

Bath & Body Works Stock Down 1.3%

BBWI opened at $18.67 on Friday. The firm has a market capitalization of $3.76 billion, a P/E ratio of 5.10, a PEG ratio of 0.93 and a beta of 1.31. The stock has a fifty day moving average of $19.24 and a 200-day moving average of $19.75. Bath & Body Works has a 12-month low of $14.27 and a 12-month high of $24.94.

Bath & Body Works (NYSE:BBWI – Get Free Report) last issued its quarterly earnings results on Thursday, November 19th. The company reported $0.26 earnings per share for the quarter, beating analysts’ consensus estimates of $0.12 by $0.14. The business had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.55 billion. Bath & Body Works had a negative return on equity of 57.47% and a net margin of 10.32%. Bath & Body Works’s revenue for the quarter was down 1.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.37 earnings per share. Bath & Body Works has set its Q4 2026 guidance at 1.410-1.610 EPS and its FY 2026 guidance at 2.600-2.800 EPS. On average, analysts expect that Bath & Body Works will post 2.77 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Allworth Financial LP boosted its holdings in Bath & Body Works by 3.1% in the third quarter. Allworth Financial LP now owns 17,371 shares of the company’s stock worth $277,000 after purchasing an additional 521 shares in the last quarter. Pathstone Holdings LLC raised its holdings in Bath & Body Works by 1.1% during the third quarter. Pathstone Holdings LLC now owns 52,031 shares of the company’s stock valued at $828,000 after buying an additional 581 shares in the last quarter. Parallel Advisors LLC raised its holdings in Bath & Body Works by 35.5% during the first quarter. Parallel Advisors LLC now owns 2,570 shares of the company’s stock valued at $48,000 after buying an additional 673 shares in the last quarter. Rothschild Investment LLC lifted its position in shares of Bath & Body Works by 12.5% in the third quarter. Rothschild Investment LLC now owns 7,570 shares of the company’s stock worth $121,000 after buying an additional 841 shares during the last quarter. Finally, GAMMA Investing LLC lifted its position in shares of Bath & Body Works by 40.7% in the second quarter. GAMMA Investing LLC now owns 5,050 shares of the company’s stock worth $117,000 after buying an additional 1,460 shares during the last quarter. Institutional investors own 95.14% of the company’s stock.

Key Bath & Body Works News

These are some of the BBWI news items that stood out recently:

  • Positive Sentiment: The company raised its full-year sales outlook and announced a new $500 million share-repurchase program. It maintained adjusted FY2026 EPS guidance of $2.60–$2.80. Bath & Body Works Q3 results and outlook
  • Neutral Sentiment: A limited-edition holiday fragrance collection with Pantone adds a product and gifting initiative, though its near-term financial impact is unclear. Bath & Body Works and Pantone holiday collection
  • Negative Sentiment: Q4 EPS guidance of $1.41–$1.61 came in below the $1.72 analyst consensus, with revenue guidance also below expectations at the midpoint. Reports of softer expected holiday sales add to concerns about near-term demand. Bath & Body Works trims FY26 EPS outlook

Bath & Body Works Company Profile

(Get Free Report)

Bath & Body Works, Inc. is a specialty retailer focused on personal care and home fragrance products. Its offerings include body lotions, soaps, fragrances, hand sanitizers, candles and other home-fragrance items, sold under the Bath & Body Works and White Barn brands. The company serves customers through its stores and e-commerce platform in the United States and Canada, as well as through international franchise, license and wholesale partners. Bath & Body Works traces its roots to a store launched in 1990.

Further Reading

Analyst Recommendations for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.